Claire Hernon is currently an MBA candidate at Harvard Business School, having commenced studies in August 2024. Prior to this role, Claire held positions at Rallybio as Associate Director of Corporate Strategy & New Product Planning from April 2022 to March 2024, and at Viatris as Senior Manager in Global Business Development and Strategy, Portfolio Decisions, and Analysis from May 2021 to March 2022. Claire's earlier experience includes working as a Senior Consultant, Consultant, Senior Analyst, and Analyst at ClearView Healthcare Partners from August 2018 to May 2021, with earlier roles as a Research Assistant at Brown University and Takeda Oncology. Claire earned a Bachelor's degree in Human Biology from Brown University and a High School Diploma from Milton Academy.